A Clinical Trial to Evaluate the Pharmacokinetics and Safety of NVP-1402 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2017
At a glance
- Drugs NVP 1402 (Primary)
- Indications CNS disorders
- Focus Pharmacokinetics
- Sponsors Navipharm
- 06 Aug 2017 Status changed from active, no longer recruiting to completed.
- 29 Mar 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 29 Dec 2016 Planned End Date changed from 1 Apr 2017 to 1 Jul 2017.